Requiring participant in federal 340B Drug Pricing Program to report certain data

West Virginia's SB 675 requires hospitals and clinics participating in the federal 340B Drug Pricing Program (called "340B covered entities") to annually report detailed financial data to the West Virginia Board of Pharmacy by April 1. This includes costs for drugs purchased under the program, payments received from insurers, payments to contracted pharmacies, and how savings are used for charity care or community health services. The data must be reported by payer type (commercial, Medicaid, Medicare), remains confidential, and the Board must then compile and publish an annual summary by November 15 for state lawmakers and the public. The bill aims to increase transparency about how 340B program savings benefit underserved patients.